LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 11

Search options

  1. Article: Exploring Factors Influencing Changes in Incidence and Severity of Multisystem Inflammatory Syndrome in Children.

    Castaldo, Pasquale / d'Alanno, Gabriele / Biserni, Giovanni Battista / Moratti, Mattia / Conti, Francesca / Fabi, Marianna / Lanari, Marcello

    Pathogens (Basel, Switzerland)

    2023  Volume 12, Issue 8

    Abstract: Multisystem inflammatory syndrome (MIS-C) is a rare condition associated with COVID-19 affecting children, characterized by severe and aberrant systemic inflammation leading to nonspecific symptoms, such as gastrointestinal, cardiac, respiratory, ... ...

    Abstract Multisystem inflammatory syndrome (MIS-C) is a rare condition associated with COVID-19 affecting children, characterized by severe and aberrant systemic inflammation leading to nonspecific symptoms, such as gastrointestinal, cardiac, respiratory, hematological, and neurological disorders. In the last year, we have experienced a progressive reduction in the incidence and severity of MIS-C, reflecting the worldwide trend. Thus, starting from the overall trend in the disease in different continents, we reviewed the literature, hypothesizing the potential influencing factors contributing to the reduction in cases and the severity of MIS-C, particularly the vaccination campaign, the spread of different SARS-CoV-2 variants (VOCs), and the changes in human immunological response. The decrease in the severity of MIS-C and its incidence seem to be related to a combination of different factors rather than a single cause. Maturation of an immunological memory to SARS-CoV-2 over time, the implication of mutations of key amino acids of S protein in VOCs, and the overall immune response elicited by vaccination over the loss of neutralization of vaccines to VOCs seem to play an important role in this change.
    Language English
    Publishing date 2023-07-30
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2695572-6
    ISSN 2076-0817
    ISSN 2076-0817
    DOI 10.3390/pathogens12080997
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Current Views on Infective Endocarditis: Changing Epidemiology, Improving Diagnostic Tools and Centering the Patient for Up-to-Date Management.

    Cimmino, Giovanni / Bottino, Roberta / Formisano, Tiziana / Orlandi, Massimiliano / Molinari, Daniele / Sperlongano, Simona / Castaldo, Pasquale / D'Elia, Saverio / Carbone, Andreina / Palladino, Alberto / Forte, Lavinia / Coppolino, Francesco / Torella, Michele / Coppola, Nicola

    Life (Basel, Switzerland)

    2023  Volume 13, Issue 2

    Abstract: Infective endocarditis (IE) is a rare but potentially life-threatening disease, sometimes with longstanding sequels among surviving patients. The population at high risk of IE is represented by patients with underlying structural heart disease and/or ... ...

    Abstract Infective endocarditis (IE) is a rare but potentially life-threatening disease, sometimes with longstanding sequels among surviving patients. The population at high risk of IE is represented by patients with underlying structural heart disease and/or intravascular prosthetic material. Taking into account the increasing number of intravascular and intracardiac procedures associated with device implantation, the number of patients at risk is growing too. If bacteremia develops, infected vegetation on the native/prosthetic valve or any intracardiac/intravascular device may occur as the final result of invading microorganisms/host immune system interaction. In the case of IE suspicion, all efforts must be focused on the diagnosis as IE can spread to almost any organ in the body. Unfortunately, the diagnosis of IE might be difficult and require a combination of clinical examination, microbiological assessment and echocardiographic evaluation. There is a need of novel microbiological and imaging techniques, especially in cases of blood culture-negative. In the last few years, the management of IE has changed. A multidisciplinary care team, including experts in infectious diseases, cardiology and cardiac surgery, namely, the Endocarditis Team, is highly recommended by the current guidelines.
    Language English
    Publishing date 2023-01-30
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2662250-6
    ISSN 2075-1729
    ISSN 2075-1729
    DOI 10.3390/life13020377
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Cardiovascular Effects of Weight Loss in Obese Patients with Diabetes: Is Bariatric Surgery the Additional Arrow in the Quiver?

    Bottino, Roberta / Carbone, Andreina / Formisano, Tiziana / D'Elia, Saverio / Orlandi, Massimiliano / Sperlongano, Simona / Molinari, Daniele / Castaldo, Pasquale / Palladino, Alberto / Barbareschi, Consiglia / Tolone, Salvatore / Docimo, Ludovico / Cimmino, Giovanni

    Life (Basel, Switzerland)

    2023  Volume 13, Issue 7

    Abstract: Obesity is an increasingly widespread disease worldwide because of lifestyle changes. It is associated with an increased risk of cardiovascular disease, primarily type 2 diabetes mellitus, with an increase in major cardiovascular adverse events. ... ...

    Abstract Obesity is an increasingly widespread disease worldwide because of lifestyle changes. It is associated with an increased risk of cardiovascular disease, primarily type 2 diabetes mellitus, with an increase in major cardiovascular adverse events. Bariatric surgery has been shown to be able to reduce the incidence of obesity-related cardiovascular disease and thus overall mortality. This result has been shown to be the result of hormonal and metabolic effects induced by post-surgical anatomical changes, with important effects on multiple hormonal and molecular axes that make this treatment more effective than conservative therapy in determining a marked improvement in the patient's cardiovascular risk profile. This review, therefore, aimed to examine the surgical techniques currently available and how these might be responsible not only for weight loss but also for metabolic improvement and cardiovascular benefits in patients undergoing such procedures.
    Language English
    Publishing date 2023-07-13
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2662250-6
    ISSN 2075-1729
    ISSN 2075-1729
    DOI 10.3390/life13071552
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Atypical presentation of a wandering spleen in niemann-pick disease.

    Centonze, Antonella / Mazzei, Aurelio / Castaldo, Pasquale / Raiola, Giuseppe / Salerno, Domenico / Porta, Ilaria Prosperi / Baldassarre, Emanuele

    The Journal of emergency medicine

    2013  Volume 44, Issue 4, Page(s) 851–852

    MeSH term(s) Abdomen, Acute/etiology ; Female ; Humans ; Wandering Spleen/complications
    Language English
    Publishing date 2013-04
    Publishing country United States
    Document type Comment ; Letter
    ZDB-ID 605559-x
    ISSN 0736-4679
    ISSN 0736-4679
    DOI 10.1016/j.jemermed.2012.05.038
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Il turismo con l'estero dell'Italia

    Chiesa, Carlo / Castaldo, Pasquale

    Rivista internazionale di scienze economiche e commerciali : RiSEC ; pubblicazione trimestrale Vol. 31, No. 7 , p. 639-348

    1984  Volume 31, Issue 7, Page(s) 639–348

    Author's details Carlo Chiesa e Pasquale Castaldo
    Keywords Reiseverkehr ; Italien
    Publisher CEDAM
    Publishing place Padova
    Document type Article
    Note mit engl. Zsfassung
    ZDB-ID 4636x
    Database ECONomics Information System

    More links

    Kategorien

  6. Article: Il vincolo esterno in Italia, Germania e Francia

    Castaldo, Pasquale / Palmisani, Fabrizio / Rossi, Salvatore

    Rivista di politica economica Ser. 3,76 ,5, S. 659-689

    elementi per un'analisi empirica comporativa

    1986  

    Author's details P. Castaldo ; F. Palmisani ; S. Rossi
    Keywords Internationale Wirtschaft ; Italien ; Frankreich ; Deutschland
    Language Italian
    Publishing place Roma
    Document type Article
    Note Literaturverz. S. 688 - 689. - Enth. 22 Tab
    ZDB-ID 4642-5
    ISSN 0035-6468
    Database ECONomics Information System

    More links

    Kategorien

  7. Article: Homocysteine and Chronic Renal Failure

    Perna, Alessandra / Castaldo, Pasquale / De Santo, Natale / Galletti, Patrizia / Ingrosso, Diego

    Mineral and Electrolyte Metabolism

    2000  Volume 25, Issue 4-6, Page(s) 279–285

    Abstract: Homocysteine, a sulfur amino acid, is an important methionine derivative, which has been implicated in the pathogenesis of atherothrombosis. Although only observational, epidemiological studies are available at present, the evidence of an association ... ...

    Institution Division of Nephrology and Institute of Biochemistry of Macromolecules, Second University of Naples, School of Medicine, Naples, Italy
    Abstract Homocysteine, a sulfur amino acid, is an important methionine derivative, which has been implicated in the pathogenesis of atherothrombosis. Although only observational, epidemiological studies are available at present, the evidence of an association between hyperhomocysteinemia and increased cardiovascular risk is quite strong and this is confirmed also in a population of chronic renal failure patients. From a biochemical standpoint at least three mechanisms have been so far summoned in order to explain homocysteine toxicity including: oxidation, hypomethylation, and acylation. Proteins are believed to play a crucial role as homocysteine molecular targets. Interference with the functions of several of such macromolecules has been so far described being mediated by any of the above mechanisms. Vitamins may positively influence homocysteine metabolism, thus facilitating the metabolic clearance of this compound. Therefore they are presently considered as potential means for reducing plasma levels of this amino acid and preventing vascular occlusions in hyperhomocysteinemic patients. These compounds, with special regard to folate, are eligible for interventional clinical trials, from which the definitive answer on the role of homocysteine in atherothrombosis is expected.
    Keywords Homocysteine ; Hypomethylation ; Uremia ; S-adenosylhomocysteine
    Language English
    Publishing date 2000-02-13
    Publisher S. Karger AG
    Publishing place Basel, Switzerland
    Document type Article
    Note Paper
    ZDB-ID 1482979-4
    ISBN 978-3-8055-7018-3 ; 978-3-318-00538-7 ; 3-8055-7018-X ; 3-318-00538-X
    ISSN 1423-016X ; 0378-0392
    ISSN (online) 1423-016X
    ISSN 0378-0392
    DOI 10.1159/000057460
    Database Karger publisher's database

    More links

    Kategorien

  8. Article ; Online: Homocysteine and Chronic Renal Failure

    Perna, Alessandra / Castaldo, Pasquale / De Santo, Natale / Galletti, Patrizia / Ingrosso, Diego

    Mineral and Electrolyte Metabolsim

    1999  Volume 25, Issue 4-6, Page(s) 279–285

    Abstract: Homocysteine, a sulfur amino acid, is an important methionine derivative, which has been implicated in the pathogenesis of atherothrombosis. Although only observational, epidemiological studies are available at present, the evidence of an association ... ...

    Abstract Homocysteine, a sulfur amino acid, is an important methionine derivative, which has been implicated in the pathogenesis of atherothrombosis. Although only observational, epidemiological studies are available at present, the evidence of an association between hyperhomocysteinemia and increased cardiovascular risk is quite strong and this is confirmed also in a population of chronic renal failure patients.From a biochemical standpoint at least three mechanisms have been so far summoned in order to explain homocysteine toxicity including: oxidation, hypomethylation, and acylation. Proteins are believed to play a crucial role as homocysteine molecular targets. Interference with the functions of several of such macromolecules has been so far described being mediated by any of the above mechanisms.Vitamins may positively influence homocysteine metabolism, thus facilitating the metabolic clearance of this compound. Therefore they are presently considered as potential means for reducing plasma levels of this amino acid and preventing vascular occlusions in hyperhomocysteinemic patients. These compounds, with special regard to folate, are eligible for interventional clinical trials, from which the definitive answer on the role of homocysteine in atherothrombosis is expected.
    Keywords Homocysteine ; Hypomethylation ; Uremia ; S-adenosylhomocysteine
    Language English
    Publisher S. Karger AG
    Publishing place Basel
    Publishing country Switzerland
    Document type Article ; Online
    ZDB-ID 80461-7
    ISBN 3-8055-7018-X ; 978-3-8055-7018-3
    ISSN 1423-016X ; 0378-0392 ; 0378-0392
    ISSN (online) 1423-016X
    ISSN 0378-0392
    DOI 10.1159/000057460
    Database Karger publisher's database

    More links

    Kategorien

  9. Article ; Online: Homocysteine, a New Crucial Element in the Pathogenesis of Uremic Cardiovascular Complications

    Perna, Alessandra / Ingrosso, Diego / Castaldo, Pasquale / De Santo, Natale / Galletti, Patrizia / Zappia, Vincenzo

    Mineral and Electrolyte Metabolism

    1999  Volume 25, Issue 1-2, Page(s) 95–99

    Abstract: Most large observational studies available today establish that moderate hyperhomocysteinemia, either genetically or nutritionally determined, is an independent risk factor for myocardial infarction, stroke, and thromboembolic disease. This is also true ... ...

    Abstract Most large observational studies available today establish that moderate hyperhomocysteinemia, either genetically or nutritionally determined, is an independent risk factor for myocardial infarction, stroke, and thromboembolic disease. This is also true for chronic renal failure patients, who exhibit a high prevalence of hyperhomocysteinemia (85-100%), which reaches high plasma concentrations (20-40 μM, while control values range between 8 and 12 μM−). After a renal transplant, homocysteine levels decrease, but tend to be higher than normal. The cause of hyperhomocysteinemia in renal failure is still obscure, since recent data have questioned the previous notion that a net homocysteine renal extraction and/or excretion take place in man. No matter the cause of its increase, the sulfur amino acid homocysteine is thought to induce an increment in cardiovascular risk through three basic biochemical mechanisms: (1) homocysteine oxidation, with H2O2 generation; (2) hypomethylation through S-adenosylhomocysteine accumulation, and (3) protein acylation by homocysteine thiolactone. The final result is membrane protein damage, endothelial damage, and endothelial cell growth inhibition, among other effects. Hyperhomocysteinemia, in general, is susceptible of therapeutic intervention with the vitamins involved in its metabolism. Depending on the cause, vitamin B6, vitamin B12, betaine, and/or folic acid can be effectively utilized. Chronic renal failure patients benefit from folic acid in high dosage: 1-2 mg are usually not effective (‘relative folate resistance’), while 5-15 mg reduce homocysteine levels to a ‘normative’ range (<15 μM) in a substantial group of patients. Good results are also obtained in transplant patients, best with a combination of folic and vitamin B6. The results of the interventional trials focusing on the possible reduction in cardiovascular risk after homocysteine-lowering therapy, both in the general population and in end-stage renal disease, are expected soon, as well as the genetic and biochemical studies in suitable models, with the aim to clarify the cause-effect link suggested by the numerous observational and basic science studies.
    Keywords Hyperhomocysteinemia ; Uremia ; Folate therapy ; Adenosylhomocysteine ; Cardiovascular risk factors
    Language English
    Publisher S. Karger AG
    Publishing place Basel
    Publishing country Switzerland
    Document type Article ; Online
    ZDB-ID 80461-7
    ISBN 3-8055-6859-2 ; 978-3-8055-6859-3
    ISSN 1423-016X ; 0378-0392 ; 0378-0392
    ISSN (online) 1423-016X
    ISSN 0378-0392
    DOI 10.1159/000057428
    Database Karger publisher's database

    More links

    Kategorien

  10. Article: Homocysteine, a New Crucial Element in the Pathogenesis of Uremic Cardiovascular Complications

    Perna, Alessandra / Ingrosso, Diego / Castaldo, Pasquale / De Santo, Natale / Galletti, Patrizia / Zappia, Vincenzo

    Mineral and Electrolyte Metabolism

    1999  Volume 25, Issue 1-2, Page(s) 95–99

    Abstract: Most large observational studies available today establish that moderate hyperhomocysteinemia, either genetically or nutritionally determined, is an independent risk factor for myocardial infarction, stroke, and thromboembolic disease. This is also true ... ...

    Institution Institute of Biochemistry of Macromolecules and Division of Nephrology/Department of Pediatrics, School of Medicine, Second University of Naples, Italy
    Abstract Most large observational studies available today establish that moderate hyperhomocysteinemia, either genetically or nutritionally determined, is an independent risk factor for myocardial infarction, stroke, and thromboembolic disease. This is also true for chronic renal failure patients, who exhibit a high prevalence of hyperhomocysteinemia (85–100%), which reaches high plasma concentrations (20–40 µM, while control values range between 8 and 12 µM). After a renal transplant, homocysteine levels decrease, but tend to be higher than normal. The cause of hyperhomocysteinemia in renal failure is still obscure, since recent data have questioned the previous notion that a net homocysteine renal extraction and/or excretion take place in man. No matter the cause of its increase, the sulfur amino acid homocysteine is thought to induce an increment in cardiovascular risk through three basic biochemical mechanisms: (1) homocysteine oxidation, with H2O2 generation; (2) hypomethylation through S-adenosylhomocysteine accumulation, and (3) protein acylation by homocysteine thiolactone. The final result is membrane protein damage, endothelial damage, and endothelial cell growth inhibition, among other effects. Hyperhomocysteinemia, in general, is susceptible of therapeutic intervention with the vitamins involved in its metabolism. Depending on the cause, vitamin B6, vitamin B12, betaine, and/or folic acid can be effectively utilized. Chronic renal failure patients benefit from folic acid in high dosage: 1–2 mg are usually not effective (‘relative folate resistance’), while 5–15 mg reduce homocysteine levels to a ‘normative’ range (<15 µM) in a substantial group of patients. Good results are also obtained in transplant patients, best with a combination of folic and vitamin B6. The results of the interventional trials focusing on the possible reduction in cardiovascular risk after homocysteine-lowering therapy, both in the general population and in end-stage renal disease, are expected soon, as well as the genetic and biochemical studies in suitable models, with the aim to clarify the cause-effect link suggested by the numerous observational and basic science studies.
    Keywords Cardiovascular risk factors ; Hyperhomocysteinemia ; Uremia ; Folate therapy ; Adenosylhomocysteine
    Language English
    Publishing date 1999-04-17
    Publisher S. Karger AG
    Publishing place Basel, Switzerland
    Document type Article
    Note Paper
    ZDB-ID 1482979-4
    ISBN 978-3-8055-6859-3 ; 978-3-318-00421-2 ; 3-8055-6859-2 ; 3-318-00421-9
    ISSN 1423-016X ; 0378-0392
    ISSN (online) 1423-016X
    ISSN 0378-0392
    DOI 10.1159/000057428
    Database Karger publisher's database

    More links

    Kategorien

To top